Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID)...
Why Is Tandem Diabetes (TNDM) Stock Soaring Today
1 of Wall Street’s Favorite Stock on Our Buy List and 2 Facing Headwinds
3 Small-Cap Stocks We Keep Off Our Radar
Tandem Diabetes’s Q1 Earnings Call: Our Top 5 Analyst Questions
3 Healthcare Stocks We’re Skeptical Of
Tandem Diabetes Care (NASDAQ:TNDM) reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel...
Why Tandem Diabetes (TNDM) Shares Are Trading Lower Today
TNDM Q1 Deep Dive: Margin Expansion and Pipeline Advances Amid Business Model Shift
Tandem Diabetes’s (NASDAQ:TNDM) Q1 CY2026: Beats On Revenue, Stock Jumps 10.9%